Mitogen-activated protein kinase (MAPK)-docking sites in MAPK kinases function as tethers that are crucial for MAPK regulation in vivo
- 31 January 2006
- journal article
- Published by Elsevier BV in Cellular Signalling
- Vol. 18 (1), 123-134
- https://doi.org/10.1016/j.cellsig.2005.04.001
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibitionNature Structural & Molecular Biology, 2004
- p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseasesNature Reviews Drug Discovery, 2003
- Mutations of the BRAF gene in human cancerNature, 2002
- Kinase Suppressor of Ras (KSR) Is a Scaffold Which Facilitates Mitogen-Activated Protein Kinase Activation In VivoMolecular and Cellular Biology, 2002
- KSR is a scaffold required for activation of the ERK/MAPK moduleGenes & Development, 2002
- Docking Sites on Substrate Proteins Direct Extracellular Signal-regulated Kinase to Phosphorylate Specific ResiduesJournal of Biological Chemistry, 2001
- The structural basis for substrate recognition and control by protein kinases1FEBS Letters, 1998
- Structure-Function Studies of p38 Mitogen-activated Protein KinaseJournal of Biological Chemistry, 1997
- Subcellular localization of annexin V in human foreskin fibroblasts: nuclear localization depends on growth stateFEBS Letters, 1996
- Transformation of Mammalian Cells by Constitutively Active MAP Kinase KinaseScience, 1994